Stay updated on Cabozantinib for Merkel Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page’s footer revision/version label was updated from v3.5.2 to v3.5.3, indicating a software/release update without changing the displayed study details.
    Difference
    0.1%
    Check dated 2026-04-24T16:51:14.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T13:33:09.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added Cutaneous neuroendocrine carcinoma as a related term and introduced a Resources section with a link to the Genetic and Rare Diseases Information Center. These changes expand contextual references but do not modify the study’s core details, eligibility criteria, outcomes, or locations.
    Difference
    0.2%
    Check dated 2026-04-03T05:30:38.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T21:14:18.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T20:10:04.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Footer revision indicator updated from v3.4.1 to v3.4.2; no other content or study details appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:39:54.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Merkel Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.